MOH · NYSE · STOCK
Molina Healthcare (MOH) Stock Analysis
$200.83
52W $121.06 – $244.89
56/100
$10.48B
—
0.75
Is MOH Bullish or Bearish?
Mixed.
Innellis AI committee rates Molina Healthcare, Inc. (MOH) Watch with a composite score of 56/100
, based on 5 analysts with 40% agreement.
Last updated September 06, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +3.97 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -16.03 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — growth rate is decelerating quarter over quarter -- the trend line matters more than the level. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- ROE of only -0.2% -- cheap may mean cheap for a reason — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of September 06, 2026
Overall Committee Score
56/100
Agreement
40%
Analysts
5
Conviction
Contested
Sector Rank
Top 80%
of 192 Healthcare peers
Value Analyst
neutral
42
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− ROE of only -0.2% -- cheap may mean cheap for a reason
Growth Analyst
bearish
38
/ 100 · Moderate confidence
Growth story is weak, decelerating, or inconsistent
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Macro Analyst
bullish
80
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
bullish
62
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2704.43)
Investment Thesis Evolution
Committee score moved marginally from 56.0 to 56.0.
Comparing 2026-09-05 to 2026-09-06 (1 day apart).
Technical Analysis
RSI (14)
48.3
Neutral
MACD Histogram
0.584
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Mixed
Support
$186.95
Resistance
$202.60
Bollinger %B
0.45
Inside Bands
Price vs Moving Averages
EMA 9
$201.28
Below
EMA 21
$201.84
Below
EMA 50
$202.44
Below
EMA 200
$192.93
Above
Fundamental Analysis
Valuation
62
Growth
39
Profitability
31
Financial Health
75
Cash Flow
70
Valuation
P/E Ratio
—
P/B Ratio
2.47×
PEG Ratio
-12.65
Dividend Yield
0.00%
52W High
$244.89
52W Low
$121.06
Quality & Growth
ROE
1160.0%
ROA
303.3%
Gross Margin
3456.0%
Operating Margin
66.5%
Revenue Growth YoY
—
Debt / Equity
0.95
AI Fundamental Assessment
P/E ratio of 1255.0 (rich relative to a 15-40x range); Price-to-book of 2.5x; PEG ratio of -12.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 11.6%; Return on assets of 3.0%; Net margin of -0.0%; Gross margin of 34.6%; Current ratio of 1.68 (healthy short-term liquidity); Debt-to-equity of 0.95; Free cash flow per share is positive (5.28); Most recent quarter beat estimates by 7.5%; 2 consecutive earnings beats; EPS growth decelerating (+185.5% -> -35.7% QoQ); Analyst estimates rising over recent quarters
Get the Full MOH Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →